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Abstract
Objective—The goal of this study was to examine associations between physicians’ clinical 
assessments, their certainty in these assessments, and the likelihood of a patient-centered 
recommendation about colorectal cancer (CRC) screening in the elderly.
Methods—Two hundred seventy six primary care physicians in the United States read three 
vignettes about an 80 year old female patient and answered questions about her life expectancy, 
their confidence in their life expectancy estimate, the balance of benefits/downsides of CRC 
screening, their certainty in their benefit/downside assessment, and the best course of action 
regarding CRC screening. We used logistic regression to determine the relationship between these 
variables and patient-centered recommendations about CRC screening.
1Financial support for this study was provided in part for Dr. Lewis by a grant from the National Cancer Institute (K07 CA104428); 
for Dr. Pignone by a grant from National Cancer Institute (K05 CA129166); and for Dr. Esserman by a grant from the NIH CTSA 
(UL1TR000142; UL1TR000083). The funding agreements ensured the authors’ independence in designing the study, interpreting the 
data, writing, and publishing the report.
CORRESPONDING AUTHOR: Carmen L. Lewis, MD, MPH, Division of General Internal Medicine, Department of Medicine, 
University of Colorado School of Medicine, Mail Stop B180, Academic Office 1, Room 8415, 12631 E. 17th Ave. Aurora, CO 80045, 
Tel (303) 724-8285 Fax (303) 724-2270, carmen.l.lewis@ucdenver.edu. 
An earlier version of this work was presented at the 2013 Annual Meeting of the Society of General Internal Medicine, in Denver, CO.
The authors report no conflicts of interest related to this study.
HHS Public Access
Author manuscript
Med Decis Making. Author manuscript; available in PMC 2016 May 01.
Published in final edited form as:













Results—In bivariate analyses, physicians had higher odds of making a patient-centered 
recommendation about CRC screening when their clinical assessments did not lead to a clear 
screening recommendation or when they experienced uncertainty in their clinical assessments. 
However, in a multivariate regression model, only benefit/downside assessment and best course of 
action remained statistically significant predictors of a patient-centered recommendation.
Conclusions—Our findings demonstrate that when the results of clinical assessments do not 
lead to obvious screening decisions or when the physician feels uncertain about their clinical 
assessments, they are more likely to make patient-centered recommendations. Existing uncertainty 
frameworks do not adequately describe the uncertainty associated with patient-centered 
recommendations found in this study. Adapting or modifying these frameworks to better reflect 
the constructs associated with uncertainty and the interactions between uncertainty and the 
complexity inherent in clinical decisions will facilitate a more complete understanding of how and 
when physicians choose to include patients in clinical decisions.
Introduction
Medical uncertainty in the primary care setting has been well-documented (1–3) and 
researchers have developed strategies for categorizing, coping with, reducing, and 
communicating uncertainty in a variety of medical settings. (e.g. 4–6) However, while 
physicians and patients can manage and reduce uncertainty through various means, they can 
rarely – if ever – eliminate it. Not surprisingly, physicians perceive and react to medical 
uncertainty differently. Because physicians’ reactions to uncertainty may influence their 
decision making, a critical component of medical care, it is important to understand how 
physicians perceive and respond to uncertainty. Previous research has documented 
physicians’ varying reactions to uncertainty. (7) These reactions can, in turn, affect how 
doctors practice medicine, including how they interpret mammograms (8), their willingness 
to communicate with patients (9), the costs associated with their care (10), and their 
willingness to engage in shared decision making (11).
Despite the extent of research about uncertainty, it remains a complex concept. Multiple 
frameworks have been proposed for understanding and classifying uncertainty which 
attempt to distinguish among multiple types and sources of uncertainty. (2,5,12) For 
example, technical uncertainty (12) or ambiguity (2,5) may arise because the information 
needed simply does not exist – there isn’t sufficient or appropriate research or the 
information is simply unknown. Conceptual uncertainty (12), complexity (2), or risk (5) 
stems from the challenges inherent to applying data or guidelines generated at the population 
level to specific situations for individual patients. This type of uncertainty includes the 
inability to know which patients will experience a complication or negative outcome from a 
procedure or treatment, or how to apply treatment guidelines to a specific patient, especially 
when that patient’s characteristics do not precisely match those in the guidelines. Finally, 
uncertainty that stems from uncertainty about patients’ preferences, wishes, or goals of care 
may also be at play, often referred to as personal uncertainty. (2,12) These frameworks are 
useful when conceptualizing uncertainty because they distinguish among uncertainty from 
unknown or unknowable data, uncertainty related to the inability to apply risk information to 
specific individuals, and uncertainty about an individual’s unique characteristics (5),
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One area in which clinicians face relatively high levels of uncertainty is in elderly patients 
with complex medical problems. Clinicians face uncertainty when there is limited evidence 
directly relevant to this population, such as when the elderly are not included in research or 
treatment guidelines. Additionally, clinicians may face uncertainty because standard clinical 
guidelines may not directly apply to an individual within a population, and physicians often 
individualize certain decisions based on an individual’s health states and life expectancies, 
rather than on standard clinical guidelines. (13,14) Further, they may face personal 
uncertainty associated with not knowing patients’ wishes or goals of care.
Colorectal cancer screening decision making in the elderly may be a useful context for 
examining physicians’ uncertainty and perceptions of this uncertainty because physicians 
may face one or more of the various types of uncertainty described above. Guidelines for 
colorectal cancer (CRC) screening endorse individualized decision making for patients ages 
75 years and older. (13,15) Variation in health state and life expectancy leads to variation in 
individuals’ likelihood of benefitting from screening. To provide individualized care about 
CRC screening, physicians must make several clinical assessments including estimating an 
individual’s life expectancy, weighing the expected benefits and downsides of CRC 
screening, and assessing whether screening is in the patient’s best interest. The uncertainty 
that physicians experience with each of these clinical assessments may differ depending on 
the clinical context. For healthy patients who have a long life expectancy (traditionally 
accepted as 10 years or more) (16), evidence indicates that CRC screening is likely 
beneficial and physicians may find recommending CRC screening a relatively easy decision 
to make. (17,18) Physicians may also find it straightforward to counsel the sickest patients 
against screening, given that they are unlikely to benefit from screening. However, for 
patients with moderate morbidities, it may be challenging to make clinical estimates 
weighing the benefits and downsides of CRC screening and determine the best course of 
action. Therefore, depending on the individual patient’s health state, physicians may have 
varying levels of uncertainty about their clinical assessments.
The purpose of this study was to understand more about the relationship between uncertainty 
and patient-centered decision making in the context of colorectal cancer screening decisions 
in the elderly. We define patient-centered recommendation as the physician initiating a 
discussion of colon cancer screening with the patient and basing their recommendation 
about colon cancer screening on that discussion. Previous studies (17,19–21) have evaluated 
physicians’ recommendations for CRC screening in the elderly. This study contributes to 
that literature by examining the association between physicians’ clinical assessments, their 
confidence and certainty in these assessments, and the likelihood of a patient-centered 
recommendation when physicians considered CRC screening in three clinical vignettes of 80 
year old women in good, fair and poor health.
Methods
This study is part of a larger study examining physicians’ recommendations for CRC 
screening in elderly patients. This paper reports physicians’ confidence and uncertainty 
when making clinical assessments about the potential benefits or downsides of CRC 
screening in case vignettes presented by survey. The Office of Human Research Ethics at the 
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University of North Carolina at Chapel Hill reviewed and approved this study and exempted 
it from written informed consent. The funding sources had no role in the study.
Participants
We used the American Medical Association Physician Masterfile to identify potentially 
eligible primary care physicians from across the US based on their self-designated primary 
specialty of practice code. We included both family physicians and general internists. We 
excluded internists who practiced a subspecialty, physicians not currently practicing, and 
geriatricians. Using these eligibility criteria, the Masterfile vendor Medical Marketing 
Service, Inc. provided a list of 5000 randomly identified eligible general internists and 
family physicians, from which we randomly selected 650 participants for study to create a 
self-weighting sample.
Screening questions at the beginning of the survey determined whether physicians 
1.)provided direct patient care involving health maintenance for patients 75 years and older 
and 2.) practiced family medicine or general internal medicine.
Mailings and Follow-up Contacts
The initial mailings occurred in January and February of 2008 and consisted of a cover 
letter, a 41-item questionnaire, a pre-addressed stamped return envelope, and a small cash 
incentive. Follow up mailings were sent to non-responders after 2 and 4 weeks.
After three mailings, we attempted to contact the non-responders via fax and offered a larger 
incentive of $50 to encourage physicians to complete the questionnaire. Physicians who 
indicated interest in participating were mailed another questionnaire.
In the event that mail was returned indicating that a physician was no longer at the last 
known address in the Masterfile, we conducted a web search to find a more recent work 
address or fax number and sent the questionnaire there.
Questionnaire
The questionnaire presented three nearly identical vignettes, each followed by an identical 
set of questions. All vignettes described an 80 year old woman with a negative previous 
colonoscopy 10 years earlier, but each vignette variably presented clinical data that placed 
the patient in good, fair, or poor health (Figure 1). All physicians saw all three vignettes. We 
purposefully chose 80 as the age of interest because the U.S. Preventive Services Task Force 
recommendations state that CRC screening should be individualized between the ages of 75 
and 84. (22) We thus examined decision making within this age group where clinical 
judgment about the risks and benefits for individuals is expected to drive screening 
recommendations. The questionnaire was comprised of 11 questions for each vignette, 5 of 
which form the basis for the analysis presented here, and an additional 8 demographic 
questions. Except where noted as such, the questions pertaining to the vignettes were Likert-
style items with five response categories, the endpoints of which are noted in parentheses 
after each question described below. The data utilized for this analysis include two types of 
questions: clinical assessments and physicians’ confidence and certainty in those clinical 
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assessments. The clinical assessment questions include: What is your best estimate of 
[Patient Name]’s life expectancy? (<2 years, 2–5 years, 6–10 years, and 10+ years); When 
balancing the potential benefits of colon cancer screening (decrease in colon cancer 
mortality) against the downsides (risk of perforation from colonoscopy, cost, discomfort, 
and inconvenience) of screening tests for [Patient’s Name], I believe that: (The benefits 
clearly outweigh the downsides – The downsides clearly outweigh the benefits); What do 
you think is the best course of action for [Patient’s Name] regarding colon cancer screening? 
(I strongly believe that undergoing screening would be in her best interest – I strongly 
believe that not undergoing screening is in her best interest). The confidence and certainty 
questions include: How confident are you in the accuracy of your life expectancy estimate 
for [Patient’s Name]? (Extremely confident – Not at all confident); How certain are you in 
the way you weighed the potential benefits of colon cancer screening against the downsides 
of screening tests for [Patient’s Name]? (Extremely certain – Extremely uncertain).
Data analysis
We used descriptive statistics to present a summary of the distribution of key variables by 
vignette. We found no differences between Family Medicine and Internal Medicine 
physicians’ characteristics or their responses for each of the vignettes and therefore 
combined the results. We used survey logistic regression techniques in SAS (Cary, NC) to 
determine the likelihood of physicians making a patient-centered recommendation.
Because we wanted to assess each step of the decision making process, we created six 
regression models. Five of the models focus on our five independent variables: life 
expectancy estimate, confidence in life expectancy estimate, benefit/downside assessment, 
certainty of benefit/downside assessment, and best course of action. We also wanted to 
explore which of these variables might be most important in influencing a patient-centered 
recommendation, so the sixth model includes all five components of the decision making 
process. In all models, we combined results from all three vignettes and controlled for 
vignette with a dummy variable.
We assessed the risk of multicollinearity by looking at the Spearman correlation between 
each of the independent predictors used in Models 1 through 5. The benefit/downside and 
best course of action constructs were the ones most highly correlated with each other, which 
could account for similarities in their univariate output. However, the relationship between 
these variables was not strong enough to cause concern with multicollinearity affecting the 
model estimates. We ran the full model including both the benefit-downsides and the best 
course of action constructs, and then we removed one or the other and compared the 
coefficient and standard error estimates and did not observe a substantial change. (23) We 
also inspected the correlation and covariance matrices of the model and did not find any 
large off diagonal terms. (24)
Results
Of the 650 questionnaires, 69 physicians were ineligible by the questionnaire’s screening 
questions and 42 physicians could not be contacted through any available address. We 
received 276 responses from eligible physicians, with a corrected response rate of 52%.
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Among the four demographic characteristics available, only specialty was associated with 
likelihood of responding, with family physicians being more likely to respond than internists 
(57% vs. 46%; p<0.01). The average age of respondents was 48 years. Seventy-one percent 
were men, and 74% were non-Hispanic white. On average, respondents reported that 27% of 
their patients were age 75 or older.
Clinical assessments and physician perceptions for each vignette
Physician responses to the clinical assessment questions varied by vignette (Table 1). For 
the good health vignette, most physicians: endorsed life expectancies of 6 or more years 
(93%), felt that the benefits of screening clearly or probably outweighed the downsides 
(77%), and believed that screening was the best course of action (79%). Conversely, for the 
poor health vignette, most physicians: endorsed a life expectancy of 5 years or less (99%), 
reported that the potential downsides of screening outweighed the benefits (85%), and did 
not believe screening was in the patient’s best interest (77%). The fair health vignette saw 
the widest distribution of responses. Most physicians endorsed a life expectancy of 2–5 
years (68%). A plurality of physicians felt that the downsides of screening probably 
outweighed the benefits (40%). More than one-third (36%) were unsure of the best course of 
action. These results demonstrate the internal validity of this study by affirming our 
expectation that screening decisions typically correlate with patients’ health status.
In response to questions about confidence and uncertainty, few physicians clearly endorsed 
options indicating low confidence or high uncertainty for any of the vignettes. However, a 
significant proportion in each vignette endorsed the neutral option, being neither confident 
nor unconfident in their life expectancy estimate (35–52%) and neither certain nor uncertain 
about their benefit/downside assessment (29%–43%). (Table 1)
Associations with patient-centered recommendations for CRC screening
Our regression results include both physicians’ clinical assessments and their perceptions of 
those assessments (Table 2). We look first at the relationships between physicians’ clinical 
assessments and the likelihood that the physician would discuss the decision with the patient 
(Models 1, 3, and 5). Regression analysis of these associations demonstrated statistically 
significant relationships (Table 2). As shown in Model 1, the odds of a patient-centered 
recommendation were higher when the patient’s life expectancy was 2–5 years [OR 2.70; 
95% CI 1.58, 4.61] or 6–10 years [OR 2.46; 95% CI 1.20, 5.08], compared to when the life 
expectancy was shorter (<2 years) or longer (10+ years). The odds of the physician 
discussing the decision with the patient were about 14 times higher [OR 13.98; 95% CI 6.76, 
28.94] when physicians felt that the benefits and downsides of screening were about equal, 
compared to when they felt the benefits clearly outweighed the downsides (Model 3). The 
results were similar when we assessed responses to the best course of action question: The 
odds of discussing the decision with the patient were about 11 times higher [OR 10.98; 95% 
CI 5.28, 22.74] when the physician was ‘Not sure whether screening is in best interest,’ 
compared to when they ‘Strongly believe screening is in best interest’ (Model 5). These 
results support our hypothesis that physicians seek greater patient involvement in the 
screening decision when their clinical assessments do not directly correspond with screening 
guidelines for or against screening.
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Next we look at the relationship between physicians’ perceptions of their clinical 
assessments and the likelihood that the patient would discuss the decision with the patient 
(Models 2 and 4). Among physicians’ perceptions of their clinical assessments, less 
confidence in their life expectancy estimate was associated with higher odds of a patient-
centered recommendation (Model 2). A physician who reported not being at all confident 
had 11.5 times higher odds of discussing the decision with the patient than a physician who 
was extremely confident [OR 11.49; 95% CI 1.23, 107.18]. Regarding certainty about the 
benefits/downsides of screening (Model 4), the odds of a physician discussing the decision 
with the patient were considerably higher when the physician was ‘neither certain nor 
uncertain’ [OR 9.27, 95% CI 3.56, 24.13] or ‘very uncertain’ [OR 6.91, 95% CI 2.04, 
23.45], compared to when they were ‘extremely certain.’ These results support our 
hypothesis that less confidence and greater uncertainty are associated with a greater 
likelihood of a patient-centered recommendation.
In the final model (Model 6), which includes all of the dependent variables – clinical 
assessments as well as physicians’ perceptions – two of the clinical assessments (benefit/
downside assessment and best course of action) remained statistically significant, while life 
expectancy estimates, confidence in life expectancy estimate, and certainty of benefit/
downside assessment were no longer statistically significant. The implications of these 
results are discussed below.
Discussion
As expected, physicians’ clinical assessments varied by the health status of the patient in 
each vignette. Most physicians reported that the benefits outweighed the harms and that 
screening was the best course of action for the good health vignette. Conversely, for the poor 
health vignette, most physicians reported that the harms outweighed the benefits and that 
screening was not in the patient’s best interest. For the fair health vignette, physicians were 
more than twice as likely to report being unsure about the best course of action (36%) than 
in to the best and worst health vignettes (15% and16%, respectively). When we explored 
associations with patient-centered recommendations – that is, seeking patient input before 
making a screening recommendation – we found that physicians have greater odds of 
making a patient-centered recommendation about CRC screening in elderly patients when 
their clinical assessments of life expectancy, the benefits and downsides of screening, and 
the best course of action do not lend themselves to a clear screening recommendation. They 
also have greater odds of a patient-centered recommendation when they are less confident 
about their assessments of the patient’s life expectancy or experience greater uncertainty in 
their assessment of the risks and benefits of screening. However, when both clinical 
assessments and physicians’ confidence and certainty in those assessments are taken 
together, as in the full regression model (Model 6), only two clinical assessments – benefit/
downside assessment and best course of action – remain statistically significant. These 
results suggest that clinicians’ subjective uncertainty in their clinical assessments may be a 
key driver in making patient centered recommendations. Interestingly, we found that few 
physicians clearly endorsed or acknowledged uncertainty in response to direct questioning 
(the confidence and certainty questions). However, a larger proportion indirectly implied 
uncertainty by indicating that they were unsure about the best course of action.
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Shared or individualized decision making has been promoted for use when the best course of 
action is a close call (25) or when the best course of action depends upon how individual 
patients value specific potential outcomes. (3) Our findings support this idea by 
demonstrating that physicians are more likely to consult with the patient before making a 
recommendation when they are uncertain or when the results of their clinical assessments do 
not suggest an obvious screening decision. These results confirm the findings of our 
previous research (18) and demonstrate that uncertainty is correlated with patient-centered 
recommendations in a national survey of physicians. The current findings also extend our 
previous research because we explored which steps in the clinical assessment are associated 
with a patient-centered recommendation..
In this study, we developed questions related to the decision making process for a specific 
clinical decision - cancer screening in the elderly. While we designed our questions to 
capture discrete steps in the clinical decision making process and examine the relationship 
between uncertainty and involving patients in the decision making process, there may be 
significant overlap in these constructs. We found that benefit/downside and best course of 
action were correlated, and though the models were stable, these constructs may indeed be 
conceptually similar. Our findings suggest that one of the challenges in examining drivers of 
patient centered care may be isolating discrete clinical steps as clinical decision making is 
such a complex cognitive task.
Consequently, existing frameworks of uncertainty may need to be extended to account for 
such complexity. For example, assessing subjective uncertainty about providers’ clinical 
assessments may be an important aspect of clinical decision making in some situations. 
Further, current frameworks may not adequately account for overlap between the types of 
uncertainty physicians experience as they make clinical decisions. For example, when 
physicians balance the benefits and downsides, they may be grappling with several types of 
uncertainty simultaneously. Our results suggest that one strategy clinicians use to address 
this uncertainty is to solicit information about the patient’s preferences and goals of care. 
This may be an effort to decrease one type of uncertainty - personal uncertainty. Extending 
existing frameworks of uncertainty to capture the interactions between types of uncertainty 
and cognitive complexity inherent in clinical decisions will facilitate a fuller understanding 
of how and when physicians choose to include patients in clinical decisions.
There are several limitations to our study. The physicians in this study responded to 
hypothetical clinical vignettes, which may not accurately capture real world decision 
making. In addition, the vignettes all discussed an 80 year old female patient and CRC 
screening, so the results may not generalize to men, the non-elderly, screening for other 
diseases, or for treatment decisions. CRC decision making may differ from decision making 
on other topics, most notably because of the long time between the decision and the 
potential for benefit – typically at least 5 years. Further, this research is exploratory. As the 
vignettes were always presented in the same order, there may have been an ordering effect. 
Due to some small cell sizes, the confidence intervals for some regression results are quite 
large, indicating a lack of precision. To confirm our findings, we have run similar models 
with collapsed variables and found roughly the same results (models not shown).
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Our findings demonstrate that when the results of clinical assessments do not lead to 
obvious screening decisions or when the physician feels uncertain about their clinical 
assessments, they are more likely to make patient-centered recommendations. Importantly, 
the uncertainty associated with patient-centered recommendations in this study is not 
adequately described by existing uncertainty frameworks. Adapting or modifying these 
frameworks to better reflect the constructs associated with uncertainty and the interactions 
between uncertainty and the complexity inherent in clinical decisions will facilitate a more 
complete understanding of how and when physicians choose to include patients in clinical 
decisions.
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 <2 years 1(0) 20(7) 181(66)
 2–5 years 17(6) 187 (68) 90(33)
 6–10 years 127(46) 66(24) 5(2)
 >10 years 131(47) 3(1) 0(0)
Confidence in Life Expectancy Estimate
 Extremely Confident 15(5) 4(1) 23(8)
 Very Confident 113(41) 102(37) 136(49)
 Neither Confident nor Unconfident 118(43) 144(52) 97(35)
 Not Very Confident 26(9) 24(9) 18(7)
 Not at all Confident 4(1) 2(1) 1(0)
Potential Benefits of Cancer Screening
 Benefits Clearly Outweigh Downsides 90 (33) 23 (8) 7 (3)
 Benefits Probably Outweigh Downsides 121 (44) 55 (20) 9 (3)
 Benefits and Downsides Equal 42 (15) 64 (23) 25 (9)
 Downsides Probably Outweigh Benefits 22 (8) 111 (40) 108 (39)
 Downsides Clearly Outweigh Benefits 1 (0) 23 (8) 126 (46)
Certainty of Benefits
 Extremely Certain 32 (12) 15 (5) 29 (11)
 Very Certain 151 (55) 128 (47) 142 (52)
 Neither Certain nor Uncertain 85 (31) 117 (43) 80 (29)
 Very Uncertain 7 (3) 12 (4) 18 (7)
 Extremely Uncertain 1 (0) 3 (1) 6 (2)
Best Course of Action
 Strongly Believe Screening is in Patient’s Best Interest 70 (25) 21 (8) 4 (1)
 Screening is Probably in Patient’s Best Interest 148 (54) 55 (20) 16 (6)
 Unsure 42 (15) 100 (36) 44 (16)
 Believe Screening is Probably NOT in Patient’s Best Interest 15 (5) 79 (29) 109 (40)
 Strongly Believe Screening is NOT in Patient’s Best Interest 0 (0) 20 (7) 102 (37)
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